Kiyokazu Atake

Plasma levels of interleukin‐6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder

Reiji Yoshimura, Hikaru Hori, Atsuko Ikenouchi et al. · Human Psychopharmacology Clinical and Experimental · 2013 · 64 citations

Medicine, Pharmacology, Psychiatry +17

Improvement of psychiatrists’ clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the ‘Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)’ project: A nationwide dissemination, education, and evaluation study

Yoshikazu Takaesu, Koichiro Watanabe, Shusuke Numata et al. · Psychiatry and Clinical Neurosciences · 2019 · 51 citations · Full text

Medicine, Psychiatry, Mental Health Education +11

PCLO rs2522833-mediated gray matter volume reduction in patients with drug-naive, first-episode major depressive disorder

Ryohei Igata, Asuka Katsuki, Shingo Kakeda et al. · Translational Psychiatry · 2017 · 49 citations · Full text

Life Sciences, Neuroscience, Psychiatry +16

Switching to antipsychotic monotherapy can improve attention and processing speed, and social activity in chronic schizophrenia patients

Hikaru Hori, Reiji Yoshimura, Asuka Katsuki et al. · Journal of Psychiatric Research · 2013 · 44 citations

Pharmacy, Pharmacotherapy, Psychiatry +16

Aripiprazole altered plasma levels of brain‐derived neurotrophic factor and catecholamine metabolites in first‐episode untreated Japanese schizophrenia patients

Reiji Yoshimura, Hikaru Hori, Atsuko Ikenouchi et al. · Human Psychopharmacology Clinical and Experimental · 2011 · 43 citations

Medicine, Pharmacology, Psychiatry +14